Sofosbuvir purchasing agent in India 15010438677 Sofosbuvir price

Buvir (also translated as sofosbuvir, English name r, trade name d) is a new drug developed by Gilead for the treatment of chronic hepatitis C. It was approved by the U.S. Food and Drug Administration (D) on the year, month, and was launched in the United States on the year, month. Approved by the European Medicines Agency for marketing in EU countries. This drug is not yet available in China and can only be obtained from foreign hospitals.
The drug is the first to safely and effectively treat certain types of hepatitis C without the need for interferon. Clinical trials have confirmed that the overall sustained virological response rate (r) of this drug combined with pegylated interferon and ribavirin is as high as % against hepatitis C. The r of this drug combined with ribavirin against hepatitis C is %-% against For hepatitis C, the r of this drug combined with ribavirin is %-%. It is worth mentioning that the clinical trials of sofosbuvir also included some patients with hepatitis C and cirrhosis, and the efficacy was significant.
The new drug Sofosbuvir for the treatment of hepatitis C has put the controversial US health care reform into another dilemma. Unable to solve health insurance spending problems, some states, including Oregon, are seeking ways to limit the supply of the drug. The expanded Medicaid program proposed by President Obama's health care reform plan has therefore been greatly reduced.
?Chronic hepatitis C can be treated with ribavirin or ribavirin + pegylated interferon. The recommended combination treatment regimen is as follows:
Single infection
Or/- Co-infection treatment regimen Treatment duration
Gene or type sofosbuvir+peginterferon-+ribavir Lin Zhou
Genotype sofosbuvir+ribavirin week
Genotype sofosbuvir+ribavirin week
?Patients with chronic hepatitis C who are unable to use interferon may be considered Weeks of treatment with sofosbuvir combined with ribavirin.
?Patients with hepatocellular carcinoma awaiting liver transplantation should be treated with sofosbuvir in combination with ribavirin for chronic hepatitis C for 10 weeks or until liver transplantation, whichever occurs first.
?Dosing recommendations cannot be made for patients with severe renal impairment or end-stage renal disease.
How long can patients with hepatitis C live? Many patients don’t pay much attention to it in the early stages of the disease. There are also many diseases that are difficult to detect because there are no symptoms in the early stages, making the disease difficult to cure in the late stages. How long can people live with hepatitis C is a concern of many patients. The problem. . So can hepatitis C be cured and how long can they live?
How long can hepatitis C patients live? It depends on many factors: the severity of the patient's condition, whether he receives scientific treatment, whether he pays attention to nursing care in life, and whether he treats the disease correctly and maintains a good attitude. It has a certain impact on the life span of hepatitis C patients.
1. Go to a regular liver disease hospital for examination and treatment in a timely manner and formulate a scientific treatment plan. Hepatitis C can be clinically cured by using appropriate therapies for professional and standardized treatment.
2. Develop good habits and eating habits, which play an important auxiliary role in the recovery of hepatitis C. It is recommended that the majority of hepatitis C patients pay attention to a light diet, pay more attention to rest, avoid tobacco, alcohol, and spicy food to avoid bad living habits that may worsen the condition.
3. Treat the disease correctly and maintain a good attitude. I believe that hepatitis C is not an incurable disease and can be cured with active treatment.